Klotho
Founded 2016 · 1 known investors
Klotho Therapeutics uses biotechnology to develop therapeutics that mimic the natural human Klotho protein to address age-related diseases including cognitive decline, kidney failure, diabetes, and cancer. The company targets treatments for conditions associated with aging in elderly and disease populations.
BiotechLongevity
Investors · 1
Frequently asked questions
- What does Klotho do?
- Klotho Therapeutics uses biotechnology to develop therapeutics that mimic the natural human Klotho protein to address age-related diseases including cognitive decline, kidney failure, diabetes, and cancer. The company targets treatments for conditions associated with aging in elderly and disease populations.
- Who are Klotho's investors?
- Klotho's investors include Thynk Capital.